Cancer Patient Empowerment Program: Phase 2 Feasibility Study
CancerPEP
CancerPEP Phase 2 Randomized Trial: Feasibility of a Comprehensive Cancer Patient Empowerment Program Providing Immediate Versus Delayed Stress Reduction Biofeedback Equipment
1 other identifier
interventional
104
1 country
1
Brief Summary
The Cancer Patient Empowerment Program is a comprehensive health promotion program aiming to improve the quality of life as well as both physical and mental health in cancer patients and survivors. The program includes daily email communications over 6 months that encourage strength and aerobic exercise, yoga, stress reduction techniques, dietary improvements, and more.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable cancer
Started Dec 2022
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2022
CompletedFirst Posted
Study publicly available on registry
August 19, 2022
CompletedStudy Start
First participant enrolled
December 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2025
CompletedMarch 18, 2026
March 1, 2026
2.4 years
August 18, 2022
March 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility (accrual, attrition, compliance, and adverse events)
As measured by accrual, attrition, compliance rates, and safety by number of adverse events.
6 - 24 months
Secondary Outcomes (18)
Mental Health as assessed by the Kessler Kessler Psychological Distress Scale (K10)
6 - 24 months
General Health (Physical and Mental) Quality of Life assessed by the 12-item Short Form Health Survey (SF-12)
6 - 24 months
Health-Related Quality of Life as assessed by the Functional Assessment of Cancer Therapy - General (FACT-G)
6 - 24 months
Personality as assessed by the Ten-Item Personality Inventory (TIPI)
6 - 24 months
Alcohol Habit assessed by questions from the NIH Alcohol Consumption questionnaire.
6 - 24 months
- +13 more secondary outcomes
Study Arms (2)
Intervention with HRV monitor
EXPERIMENTALIntervention without HRV monitor
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Age \>18.
- History of a cancer diagnosis as per the participant's report.
- Safe to exercise and do strength training. Participants who have recovered from a minor stroke or heart condition in the past will require approval from their Family Physician or Cardiologist to participate in the study.
- Participants with advanced cancer (including cancer spread to bones) will need approval from the Study Physician or their Oncologist to participate.
- Existing (or willingness to create) email account and willingness to access email daily.
- Ability to follow website links to watch YouTube videos.
- Ability to understand and speak English.
- Ability to participate in low to moderate levels of physical activity and strength training.
- Ability and willingness to fill out an online survey at baseline, and 6, 12 and possibly 24 months, and a weekly compliance survey for the six months of the program.
- Deemed to have an expected survival greater than 1 year and expected to be well enough to complete the six-month training
You may not qualify if:
- Patients deemed unfit to participate in low to moderate level exercise e.g., including but not limited to a myocardial infarction or stroke within the last year, without approval from their Family Physician or Cardiologist that they are safe to exercise.
- Unable to access the internet and lack of a computer or smartphone to receive emails required for study intervention, or unable to click on a link to successfully watch a YouTube video.
- Those with a predicted survival less than 1 year, or not expected to be able to participate in the program for six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nova Scotia Health Authoritylead
- Dalhousie Universitycollaborator
Study Sites (1)
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 2Y9, Canada
Related Publications (1)
Ilie G, Knapp G, Davidson A, Snow S, Dahn HM, MacDonald C, Tsirigotis M, Rutledge RDH. The Cancer Patient Empowerment Program: A Comprehensive Approach to Reducing Psychological Distress in Cancer Survivors, with Insights from a Mixed-Model Analysis, Including Implications for Breast Cancer Patients. Cancers (Basel). 2024 Oct 2;16(19):3373. doi: 10.3390/cancers16193373.
PMID: 39409993DERIVED
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 18, 2022
First Posted
August 19, 2022
Study Start
December 6, 2022
Primary Completion
April 13, 2025
Study Completion
April 13, 2025
Last Updated
March 18, 2026
Record last verified: 2026-03